版本:
中国

BRIEF-Regenxbio announces initiation of phase I/II clinical trial of RGX-501 for treatment of homozygous familial hypercholesterolemia

March 7 Regenxbio Inc:

* Regenxbio announces initiation of phase i/ii clinical trial of rgx-501 for the treatment of homozygous familial hypercholesterolemia

* Regenxbio announces initiation of phase i/ii clinical trial of rgx-501 for the treatment of homozygous familial hypercholesterolemia

* Regenxbio inc - "we look forward to continuing enrollment, and expect to report interim trial results by end of 2017." Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐